Cargando…
Perampanel-induced, new-onset food aversion in a 29-year-old female with medically refractory frontal lobe epilepsy
BACKGROUND: Perampanel is a selective, noncompetitive amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor antagonist indicated for management of partial-onset and primary generalized seizures in epilepsy patients aged ≥12 years. PATIENT HISTORY: A 29-year-old, white female with sig...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
College of Psychiatric & Neurologic Pharmacists
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398359/ https://www.ncbi.nlm.nih.gov/pubmed/30842918 http://dx.doi.org/10.9740/mhc.2019.03.100 |